Bird & Bird advises Alven and Daphni on Generare’s €20 million Series A

"Bird & Bird advised venture funds Alven and Daphni on Generare’s €20 million Series A round, led by Alven and Daphni with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners. Generare — a startup that uses bacterial gene exploration to access the ~97% of natural-product space still uncharted — has already identified about 200 new molecules and will use the funding to grow its portfolio to roughly 1,000 discoveries within two years and pursue a first licensing deal in pharmacology and agriculture. Bird & Bird’s deal team included partner Félicien Bardsley and Inès Louguar."